Rochester spreads knowledge of cancer-related fatigue
... Virtually all cancer patients complain of some degree of persistent fatigue. Coping with this challenging side effect is critical to surviving cancer, especially since many people desire to work, raise children, run a household, or engage in recreation throughout their treatments, said Joseph Roscoe, Ph.D....New AIDS Tech Transfers reinforce Roche commitment to strengthen African manufacturing
Basel, Tuesday 29 May 2007. Roche today announced the agreement of two new technology transfers with local manufacturing companies in Africa -- Addis Pharmaceutical Factory in Ethiopia and Varichem Pharmaceuticals in Zimbabwe. As part of Roche's Technology Transfer Initiative, these companies will be provided free of charge with the technical expertise and guidance to manufacture generic HIV med...MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
... Patients participating in the study, which is being conducted under MacroChem's U.S. Investigational New Drug application filed with the FDA, will receive 48 weeks of treatment and will undergo...Rochester study rolls out RU-486 to treat uterine fibroids
... Leiomyoma, the medical term for uterine fibroids, affects roughly half of all women aged 35 to 49. The non-cancerous tumors cause iron-deficiency anemia due to excessive menstrual bleeding, and deeply impact the quality of life for women who have this condition. Thousands of women annually opt for hysterectomies or have th...University of Rochester spin-off secures $2 million in funding
... iCardiac Technologies previously entered into an exclusive agreement with the University of Rochester to license and commercialize technology and unique biomarkers that enable pharmaceutical companies to more effectively determine whether a drug p...Rochester study shows ethnic disparities in medicare claims
... "If you ask anyone, "When was the last time you had a mammogram, or a cholesterol test?' almost all people will think it's been a shorter time than it's actually been. Over-reporting happens to al...Rochester researchers join federal initiative to improve drug safety
... The research, to be directed by Rochester researcher Jean-Philippe Couderc, Ph.D., will, for the first time, give scientists access to a huge FDA database of electrocardiograms (ECG) for the purpose of identifying early predictors of cardiac risk. This project is part of the "Critical Path" initiat...... ... This is a new avenue for scientists to pursue in an effort to find the underlying c...